Clinical Trials

Clinical trials are research studies that are designed to determine if a therapy is safe and effective for patients.

7101 Clinical Trial for Rheumatoid Arthritis

We have initiated a Phase 1 study to evaluate the safety and proof-of-mechanism of our lead Treg cell therapy candidate, SBT-77-7101, in patients with rheumatoid arthritis.

For more information, please visit our clinical trial website.

Learn More

7101 Clinical Trial for Hidradenitis Suppurativa

This study will test the safety and effects of SBT-77-7101 when given as a single dose to subjects with hidradenitis suppurativa. Increasing dose levels will be given after the safety at lower dose levels is shown.

For more information, please visit our clinical trial website.

Learn More

5301 Clinical Trial

We are conducting a Phase 1 study of SBT-11-5301, our effector T cell-modulating biologic, in healthy participants.

For more information, please see the 5301 study on ClinicalTrials.gov.

Learn More